This inventor holds 3 USPTO granted patents and 13 EPO patents. Top assignees: Unilever Home and Personal Care USA, Division of Conopco, Inc., Novozymes A/s. Active years: 2004-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Merseyside, GB (2004)
- Bebington, GB (2006 - 2020)
Company Filing History:

Years Active: 2004-2020
Title: The Innovative Mind of Andrew Paul Chapple
Introduction: Andrew Paul Chapple, hailing from Bebington, GB, is a distinguished inventor with a remarkable portfolio of three patents. His innovative contributions to the fields of enzyme technology and antibody stabilization reflect a commitment to advancing scientific knowledge and practical applications.
Latest Patents: Among his latest innovations is the "Triggered Release System," which utilizes the combination of an enzyme substrate and an enzyme designed to enhance the modification of said substrate. This system is particularly effective in retaining a rinse benefit agent during the wash phase while releasing it during the subsequent rinse phase, showcasing a clever integration of enzymatic mechanisms. Another significant patent is the "Stabilization of Antibodies or Fragments Thereof," which details an antibody granule made primarily of one or more antibodies or their derived fragments, granulated using an alkali metal salt. This invention provides a methodology for creating antibody granules that can be utilized in enzymatic stain bleaching or anti-dye transfer compositions.
Career Highlights: Andrew has built a substantial career, working with well-respected companies in the industry. Notably, he has contributed his expertise to Unilever Home and Personal Care USA, a division of Conopco, Inc., and Novozymes A/S. His work at these organizations has enabled him to apply his inventive ideas to real-world challenges, impacting the quality and effectiveness of consumer products.
Collaborations: Throughout his career, Andrew has collaborated with several accomplished professionals, including Antonius Henricus J Strijbosch and Flemming Borup. These partnerships have likely fostered a rich exchange of ideas, facilitating the development of his patented technologies and contributing to the scientific community.
Conclusion: Andrew Paul Chapple's inventive spirit and significant contributions to enzyme technology and antibody stabilization are noteworthy. His patents not only demonstrate a deep understanding of biochemical processes but also underline the importance of innovation in enhancing product efficacy in everyday applications. As he continues to push boundaries, his work will undoubtedly inspire future advancements in his field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile